{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:43:21Z","timestamp":1777286601673,"version":"3.51.4"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"63","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,5]]},"DOI":"10.18632\/oncotarget.22455","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T19:17:40Z","timestamp":1510773460000},"page":"106888-106900","source":"Crossref","is-referenced-by-count":16,"title":["Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei"],"prefix":"10.18632","volume":"8","author":[{"given":"Ashok K.","family":"Dilly","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendon D.","family":"Honick","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"},{"name":"Department of Pharmacology and Chemical Biology, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong S.","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert J.","family":"Zeh","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon A.","family":"Choudry","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh PA 15232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process","volume":"40","author":"Moran","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jso.23146","article-title":"Mucin as a therapeutic target in pseudomyxoma peritonei","volume":"106","author":"Bartlett","year":"2012","journal-title":"J Surg Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrclinonc.2015.140","article-title":"Advances in the care of patients with mucinous colorectal cancer","volume":"13","author":"Nagtegaal","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1477-7819-10-109","article-title":"The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease","volume":"10","author":"Masuda","year":"2012","journal-title":"World J Surg Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-9-71","article-title":"Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects","volume":"9","author":"Morris","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9440(10)64211-3","article-title":"Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells","volume":"161","author":"Barsky","year":"2002","journal-title":"Am J Pathol"},{"key":"7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bjc.6604955","article-title":"Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and\/or irinotecan-based chemotherapy","volume":"100","author":"Silva","year":"2009","journal-title":"Br J Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1245\/s10434-011-1612-8","article-title":"Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis","volume":"18","author":"Kim","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/bjc.2013.232","article-title":"Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy","volume":"108","author":"Park","year":"2013","journal-title":"Br J Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: Protection and control of the cell surface","volume":"4","author":"Swanson","year":"2004","journal-title":"Nature Reviews Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/modpathol.3800482","article-title":"Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component","volume":"19","author":"Fuchs","year":"2006","journal-title":"Mod Pathol"},{"key":"12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cjp2.1","article-title":"The molecular background of mucinous carcinoma beyond MUC2","volume":"1","author":"Nagtegaal","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/ijc.21701","article-title":"BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer","volume":"118","author":"Kim","year":"2006","journal-title":"Int J Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.trsl.2015.03.004","article-title":"Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth","volume":"166","author":"Choudry","year":"2015","journal-title":"Transl Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2613.2010.00721.x","article-title":"Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma","volume":"91","author":"Davison","year":"2010","journal-title":"Int J Exp Pathol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.humpath.2014.04.018","article-title":"GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival","volume":"45","author":"Pai","year":"2014","journal-title":"Hum Pathol"},{"key":"18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/gm559","article-title":"Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin","volume":"6","author":"Frazer","year":"2014","journal-title":"Genome Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"G949","DOI":"10.1152\/ajpgi.00142.2005","article-title":"Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB\/ATF1","volume":"289","author":"Kim","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1373\/clinchem.2014.225565","article-title":"Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations","volume":"60","author":"Tsapakos","year":"2014","journal-title":"Clin Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/bjc.2013.47","article-title":"Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms","volume":"108","author":"Kanai","year":"2013","journal-title":"Br J Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1002\/ijc.29245","article-title":"Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry","volume":"136","author":"Ristimaki","year":"2015","journal-title":"Int J Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/annonc\/mdw314","article-title":"Toward the molecular dissection of peritoneal pseudomyxoma","volume":"27","author":"Pellegrinelli","year":"2016","journal-title":"Ann Oncol"},{"key":"24","first-page":"D1216","article-title":"Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer?","volume":"6","author":"Aubert","year":"2001","journal-title":"Front Biosci"},{"key":"25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1023226616526","article-title":"The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase","volume":"27","author":"Peterson","year":"2003","journal-title":"Inflammation"},{"key":"26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2005.12.013","article-title":"COX-2 expression in pseudomyxoma peritonei","volume":"244","author":"Loggie","year":"2006","journal-title":"Cancer Lett"},{"key":"27","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1111\/bph.13331","article-title":"Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?","volume":"172","author":"Houston","year":"2015","journal-title":"Br J Pharmacol"},{"key":"28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Kaidi","year":"2009","journal-title":"Carcinogenesis"},{"key":"29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djj206","article-title":"Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors","volume":"98","author":"Geisslinger","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2011.01.012","article-title":"Targeting apoptosis pathways by Celecoxib in cancer","volume":"332","author":"Jendrossek","year":"2013","journal-title":"Cancer Lett"},{"key":"31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjc.6604049","article-title":"Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy","volume":"97","author":"Schonthal","year":"2007","journal-title":"Br J Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/gcc.22147","article-title":"Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma","volume":"53","author":"Kanai","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"33","first-page":"843","article-title":"Targeting protein kinase A in cancer therapy: an update","volume":"13","author":"Naviglio","year":"2014","journal-title":"EXCLI J"},{"key":"34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3346\/jkms.2002.17.6.765","article-title":"Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK\/ERK, and PI3K in human airway epithelial cells","volume":"17","author":"Baek","year":"2002","journal-title":"J Korean Med Sci"},{"key":"35","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1158\/0008-5472.CAN-08-0598","article-title":"Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation","volume":"68","author":"Augenlicht","year":"2008","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrc3521","article-title":"The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer","volume":"13","author":"Gutkind","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"37","first-page":"345","article-title":"Aspirin and COX-2 inhibitor use in patients with stage III colon cancer","volume":"107","author":"Goldberg","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1517\/13543784.17.2.197","article-title":"Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs","volume":"17","author":"Petasis","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"39","first-page":"1","article-title":"Chemoprevention of colorectal cancer: systematic review and economic evaluation","volume":"14","author":"Tappenden","year":"2010","journal-title":"Health Technol Assess"},{"key":"40","article-title":"Establishment of human epithelial enteroids and colonoids from whole tissue and biopsy","author":"Helmrath","year":"2015","journal-title":"J Vis Exp"},{"key":"41","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1245\/s10434-012-2242-5","article-title":"Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei","volume":"19","author":"Bartlett","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2015.10.006","article-title":"Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumors","volume":"169","author":"Choudry","year":"2016","journal-title":"Transl Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T18:33:57Z","timestamp":1596738837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":42,"journal-issue":{"issue":"63","published-print":{"date-parts":[[2017,12,5]]}},"alternative-id":["22455","29290997"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22455","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]}}}